Shockwave Therapy System That Targets Diabetic Foot Ulcers Cleared By FDA
The US agency has approved Sanuwave Inc.'s dermaPACE shockwave system, the first device of its kind to treat diabetic foot ulcers.
You may also be interested in...
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.